Furthermore, we demonstrate that MGMT mRNA ishomogeneously expressed throughout the solid tumor of malignant gliomas, can bereliably determined even from small sized biopsy specimens, is strongly correlatedwith outcome measurements (even for those with discordant findings), and plays adirect role for mediating tumor sensitivity to alkylating agents. This evidence concerns the gene MGMT and malignant glioma.